By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

Conduit Pharmaceuticals Inc. (CDTTW)

NASDAQ Currency in USD
$0.01
-$0.01
-29.89%
Last Update: 11 Sept 2025, 20:00
$9.73K
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.01 - $0.02
52 Week Range

CDTTW Stock Price Chart

Explore Conduit Pharmaceuticals Inc. interactive price chart. Choose custom timeframes to analyze CDTTW price movements and trends.

CDTTW Company Profile

Discover essential business fundamentals and corporate details for Conduit Pharmaceuticals Inc. (CDTTW) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

Employees

6.00

CEO

Andrew Regan

Description

Conduit Pharmaceuticals Limited operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. The company was incorporated in 2022 and is based in Grand Cayman, Cayman Islands.Conduit Pharmaceuticals Limited operates as a subsidiary of Corvus Capital Limited.

CDTTW Financial Timeline

Browse a chronological timeline of Conduit Pharmaceuticals Inc. corporate events including earnings releases, dividend announcements, and stock splits.

No results found.

CDTTW Stock Performance

Access detailed CDTTW performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run